Announced
Completed
Synopsis
Novartis, a Swiss drugmaker company, completed the acquisition of Arctos Medical, a company that specializes in gene therapy. Financial terms were not disclosed. “Optogenetics is emerging as a promising therapeutic approach that might restore sight to patients who are legally blind,” Jay Bradner, Novartis President.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.